- Home
- VOR vs HOV Comparison
VOR vs HOV Comparison
Compare VOR & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | HOV |
|---|---|---|
| Founded | 2015 | 1959 |
| Country | United States | United States |
| Employees | N/A | 1891 |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.6M | 646.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | VOR | HOV |
|---|---|---|
| Price | $12.57 | $103.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 1 |
| Target Price | $61.30 | ★ $120.00 |
| AVG Volume (30 Days) | ★ 603.6K | 67.1K |
| Earning Date | 03-20-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.30 |
| Revenue Next Year | N/A | $4.88 |
| P/E Ratio | ★ N/A | $17.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $81.15 |
| 52 Week High | $49.95 | $162.06 |
Technical Indicators
Market Signals| Indicator | VOR | HOV |
|---|---|---|
| Relative Strength Index (RSI) | 38.45 | 32.31 |
| Support Level | $11.76 | $95.86 |
| Resistance Level | $16.88 | $109.95 |
| Average True Range (ATR) | 1.02 | 5.16 |
| MACD | -0.30 | -0.99 |
| Stochastic Oscillator | 0.47 | 4.79 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About HOV Hovnanian Enterprises Inc.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.